Robert I. Haddad

2003–2026 年に発表

168: 論文数
35,054: 被引用数
91: h 指数
157: i10 指数

被引用数

引用元

国・地域

0%25.9%その他 24%

機関

分野

トピック

全論文

並び替え

検索で開く

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
著者: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison - New England Journal of Medicine 2016 被引用: 5,078
Head and neck cancer
著者: Mayur D. Mody, James W. Rocco, Sue S. Yom, Robert I. Haddad, Nabil F. Saba - The Lancet 2021 被引用: 822
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
著者: Adrienne Luoma, Shengbao Suo, Yifan Wang, Lauren Gunasti, Caroline Porter, Nancy Nabilsi, Jenny Tadros, Andrew Ferretti, Sida Liao, Cagan Gurer, Yu‐Hui Chen, Shana Criscitiello, Cora A. Ricker, Danielle Dionne, Orit Rozenblatt–Rosen, Ravindra Uppaluri, Robert I. Haddad, Orr Ashenberg, Aviv Regev, Eliezer M. Van Allen, Gavin MacBeath, Jonathan D. Schoenfeld, Kai W. Wucherpfennig - Cell 2022 被引用: 392
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
著者: Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri, Robert I. Haddad, Makoto Tahara, Jean Bourhis, Kevin J. Harrington, Peter Mu‐Hsin Chang, Jin‐Ching Lin, Mohammad Razaq, Maria Margarida Teixeira, József Lövey, J. Chamois, Antonio Rueda, Chaosu Hu, Lara Dunn, Mikhail Dvorkin, Steven De Beukelaer, Dmitri Pavlov, Holger Thurm, Ezra E.W. Cohen - The Lancet Oncology 2021 被引用: 617
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
著者: David G. Pfister, Sharon Spencer, David J. Adelstein, Douglas R. Adkins, Yoshimi Anzai, David M. Brizel, Justine Y. Bruce, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Moon J. Fenton, Robert L. Foote, Thomas J. Galloway, Maura L. Gillison, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra S. Leizman, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, James W. Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Gregory S. Weinstein, Matthew E. Witek, Frank Worden, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2020 被引用: 1,374
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
著者: Robert I. Haddad, Lindsay Bischoff, Douglas W. Ball, Victor Bernet, Erik Blomain, Naifa L. Busaidy, Michael J. Campbell, Paxton V. Dickson, Quan‐Yang Duh, Hormoz Ehya, Whitney Goldner, Theresa Guo, Megan R. Haymart, Shelby Holt, Jason P. Hunt, Andrei Iagaru, Fouad Kandeel, Dominick Lamonica, Susan J. Mandel, Stephanie Markovina, Bryan McIver, Christopher D. Raeburn, Rod Rezaee, John A. Ridge, Mara Y. Roth, Randall P. Scheri, Jatin P. Shah, Jennifer A. Sipos, Rebecca S. Sippel, Cord Sturgeon, Thomas N. Wang, Lori J. Wirth, Richard J. Wong, Michael W. Yeh, Carly J. Cassara, Susan Darlow - Journal of the National Comprehensive Cancer Network 2022 被引用: 503
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
著者: Jimmy J. Caudell, Maura L. Gillison, Ellie Maghami, Sharon Spencer, David G. Pfister, Douglas R. Adkins, Andrew C. Birkeland, David M. Brizel, Paul M. Busse, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Thomas J. Galloway, J.L. Geiger, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra S. Leizman, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, James W. Rocco, Cristina P. Rodriguez, P. Savvides, David A. Schwartz, Jatin P. Shah, David J. Sher, Maie A. St. John, Randal S. Weber, Gregory S. Weinstein, Frank Worden, Justine Y. Bruce, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2022 被引用: 531
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study
著者: Robert L. Ferris, Robert I. Haddad, Caroline Even, Makoto Tahara, Mikhail Dvorkin, Tudor–Eliade Ciuleanu, Paul M. Clément, Ricard Mesı́a, С. И. Кутукова, Lyubov Zholudeva, Amaury Daste, Javier Caballero-Daroqui, Bhumsuk Keam, Ihor Vynnychenko, C. Lafond, Jagdish Shetty, Helen Mann, Jean Fan, Sophie Wildsmith, Nassim Morsli, Jérôme Fayette, Lisa Licitra - Annals of Oncology 2020 被引用: 365
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
著者: Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo, Bhupendra Rawal, Yu‐Hui Chen, Paul Catalano, Ana Lako, Zoe Ciantra, Jason L. Weirather, Shana Criscitiello, Adrienne Luoma, Nicole G. Chau, Jochen H. Lorch, Jason Kass, Donald J. Annino, Laura A. Goguen, Anupam M. Desai, Brendan Ross, Hina Shah, Heather A. Jacene, Danielle N. Margalit, Roy B. Tishler, Kai W. Wucherpfennig, Scott J. Rodig, Ravindra Uppaluri, Robert I. Haddad - JAMA Oncology 2020 被引用: 347
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
著者: Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum, Randal C. Paniello, Jason T. Rich, Ryan S. Jackson, Patrik Pipkorn, Loren S. Michel, Jessica Ley, Peter Oppelt, Gavin P. Dunn, Erica K. Barnell, Nicholas C. Spies, Tianxiang Lin, Tiantian Li, David T. Mulder, Youstina Hanna, Iulia Cirlan, Trevor J. Pugh, Tenny Mudianto, Rachel Riley, Liye Zhou, Vickie Y. Jo, Matthew D. Stachler, Glenn J. Hanna, Jason Kass, Robert I. Haddad, Jonathan D. Schoenfeld, Evisa Gjini, Ana Lako, Wade L. Thorstad, Hiram A. Gay, Mackenzie Daly, Scott J. Rodig, Ian S. Hagemann, Dorina Kallogjeri, Jay F. Piccirillo, Rebecca D. Chernock, Malachi Griffith, Obi L. Griffith, Douglas R. Adkins - Clinical Cancer Research 2020 被引用: 365
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
著者: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Mark Lynch, Vijayvel Jayaprakash, Li Li, Maura L. Gillison - Oral Oncology 2018 被引用: 800
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
著者: Ranee Mehra, Tanguy Y. Seiwert, Shilpa Gupta, Jared Weiss, Iris Gluck, Joseph P. Eder, Barbara Burtness, Makoto Tahara, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Ravit Geva, Hyun Cheol Chung, Chia‐Chi Lin, Deepti Aurora-Garg, Archana Ray, Kumudu Pathiraja, Jonathan D. Cheng, Laura Q.M. Chow, Robert I. Haddad - British Journal of Cancer 2018 被引用: 456
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651
著者: Robert I. Haddad, Kevin J. Harrington, Makoto Tahara, Robert L. Ferris, Maura L. Gillison, Jérôme Fayette, Amaury Daste, P. Koralewski, Bogdan Żurawski, Miren Taberna, Nabil F. Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo Girotto, Miguel Ángel Álvarez-Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander Guminski, Urs Müller‐Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Wei Li, Athanassios Argiris - Journal of Clinical Oncology 2022 被引用: 158
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
著者: Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou, Cameron Messier, Patrick H. Lizotte, Kathleen L. Pfaff, Kari Stromhaug, Livius Penter, Robert I. Haddad, Glenn J. Hanna, Jonathan D. Schoenfeld, Laura A. Goguen, Donald J. Annino, Vickie Y. Jo, Peter Oppelt, Patrik Pipkorn, Ryan S. Jackson, Sidharth V. Puram, Randal C. Paniello, Jason T. Rich, J. C. Webb, José P. Zevallos, Mena Mansour, Jingxin Fu, Gavin P. Dunn, Scott J. Rodig, Jessica Ley, Luc G.T. Morris, Lara Dunn, Cloud P. Paweletz, Dorina Kallogjeri, Jay F. Piccirillo, Douglas R. Adkins, Catherine J. Wu, Ravindra Uppaluri - Science Immunology 2023 被引用: 116
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
著者: Yu‐Pei Chen, Nofisat Ismaila, Melvin L.K. Chua, A. Dimitrios Colevas, Robert I. Haddad, Shao Hui Huang, Joseph Wee, Alexander C. Whitley, Junlin Yi, Sue S. Yom, Anthony T.�C. Chan, Chaosu Hu, Jinyi Lang, Quynh‐Thu Le, Anne W.M. Lee, Nancy Y. Lee, Jin‐Ching Lin, Brigette Ma, T. J. Morgan, Jatin P. Shah, Ying Sun, Jun Ma - Journal of Clinical Oncology 2021 被引用: 391
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study
著者: Amanda Psyrri, Jérôme Fayette, Kevin J. Harrington, Maura L. Gillison, M-J. Ahn, Shunji Takahashi, Jared Weiss, J-P. Machiels, Shrujal S. Baxi, Alexander Vasilyev, А. А. Карпенко, Mikhail Dvorkin, Ching-Yun Hsieh, S.C. Thungappa, Pedro Pérez Segura, Ihor Vynnychenko, Robert I. Haddad, Stefan Kasper, P. S. Mauz, V. Baker, Philip He, Brent Evans, Sophie Wildsmith, Richard F. Olsson, Alejandro Yovine, John F. Kurland, Nassim Morsli, Tanguy Y. Seiwert - Annals of Oncology 2022 被引用: 144
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
著者: Diana Miao, Claire A. Margolis, Natalie I. Vokes, David Liu, Amaro Taylor‐Weiner, Stephanie A. Wankowicz, Dennis O. Adeegbe, Daniel Keliher, Bastian Schilling, Adam Tracy, Michael P. Manos, Nicole G. Chau, Glenn J. Hanna, Paz Polak, Scott J. Rodig, Sabina Signoretti, Lynette M. Sholl, Jeffrey A. Engelman, Gad Getz, Pasi A. Jänne, Robert I. Haddad, Toni K. Choueiri, David A. Barbie, Rizwan Haq, Mark M. Awad, Dirk Schadendorf, F. Stephen Hodi, Joaquim Bellmunt, Kwok‐Kin Wong, Peter S. Hammerman, Eliezer M. Van Allen - Nature Genetics 2018 被引用: 696
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
著者: Joshua Bauml, Tanguy Y. Seiwert, David G. Pfister, Francis P. Worden, Stephen V. Liu, Jill Gilbert, Nabil F. Saba, Jared Weiss, Lori J. Wirth, Ammar Sukari, Hyunseok Kang, Michael K. Gibson, Erminia Massarelli, Steven Powell, Amy Meister, Xinxin Shu, Jonathan D. Cheng, Robert I. Haddad - Journal of Clinical Oncology 2017 被引用: 652
Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations
著者: Alan L. Ho, Irene Braña, Robert I. Haddad, Jessica R. Bauman, Keith C. Bible, Sjoukje F. Oosting, Deborah Jean Lee Wong, Myung‐Ju Ahn, Valentina Boni, Caroline Even, Jérôme Fayette, M.J. Flor, Kevin J. Harrington, David S. Hong, Sung‐Bae Kim, Lisa Licitra, Ioanna Nixon, Nabil F. Saba, Stephan Hackenberg, Pol Specenier, Francis P. Worden, Binaifer Balsara, Mollie Leoni, Bridget Martell, Catherine Scholz, Antonio Gualberto - Journal of Clinical Oncology 2021 被引用: 196
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
著者: Laura Q.M. Chow, Robert I. Haddad, Shilpa Gupta, Amit Mahipal, Ranee Mehra, Makoto Tahara, Raanan Berger, Joseph P. Eder, Barbara Burtness, Se‐Hoon Lee, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Jared Weiss, Ravit Geva, Chia‐Chi Lin, Hyun Cheol Chung, Amy Meister, Marisa Dolled‐Filhart, Kumudu Pathiraja, Jonathan D. Cheng, Tanguy Y. Seiwert - Journal of Clinical Oncology 2016 被引用: 859
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
著者: Glenn J. Hanna, Anne O’Neill, Kee‐Young Shin, Kristine Wong, Vickie Y. Jo, Charles T. Quinn, Jennifer M. Cutler, Michelle Flynn, Patrick H. Lizotte, Donald J. Annino, Laura A. Goguen, Jason Kass, Eleni M. Rettig, Rosh K.V. Sethi, Jochen H. Lorch, Jonathan D. Schoenfeld, Danielle N. Margalit, Roy B. Tishler, Peter C. Everett, Anupam M. Desai, Megan E. Cavanaugh, Cloud P. Paweletz, Ann Marie Egloff, Ravindra Uppaluri, Robert I. Haddad - Clinical Cancer Research 2021 被引用: 103
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
著者: Kevin J. Harrington, Robert L. Ferris, Maura L. Gillison, Makoto Tahara, A. Argiris, Jérôme Fayette, Michael Schenker, Åse Bratland, John Walker, Peter Grell, Caroline Even, Christine H. Chung, Rebecca Redman, Alexandre Coutté, Sébastien Salas, Clíona Grant, Sérgio de Azevedo, Denis Soulières, Aaron R. Hansen, Wei Li, Tariq Aziz Khan, Karen Miller-Moslin, Mustimbo Roberts, Robert I. Haddad - JAMA Oncology 2023 被引用: 72
Frameshift events predict anti–PD-1/L1 response in head and neck cancer
著者: Glenn J. Hanna, Patrick H. Lizotte, Megan E. Cavanaugh, Frank C. Kuo, Priyanka Shivdasani, Alexander Frieden, Nicole G. Chau, Jonathan D. Schoenfeld, Jochen H. Lorch, Ravindra Uppaluri, Laura E. MacConaill, Robert I. Haddad - JCI Insight 2018 被引用: 279
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors
著者: Amin H. Nassar, Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl, Pier Vitale Nuzzo, Tarek H. Mouhieddine, Tomin Perea-Chamblee, Kodi Taraszka, Habib El‐Khoury, Muhieddine Labban, Christopher J. Fong, Kanika Arora, Chris Labaki, Wenxin Xu, Guru Sonpavde, Robert I. Haddad, Kent W. Mouw, Marios Giannakis, F. Stephen Hodi, Noah Zaitlen, Adam J. Schoenfeld, Nikolaus Schultz, Michael F. Berger, Laura E. MacConaill, Guruprasad Ananda, David J. Kwiatkowski, Toni K. Choueiri, Deborah Schrag, Jian Carrot‐Zhang, Alexander Gusev - Cancer Cell 2022 被引用: 116